Rare heart disease triggered by Covid vaccine is ‘mild and resolves quickly’, scientists say – .

Rare heart disease triggered by Covid vaccine is ‘mild and resolves quickly’, scientists say – .

A rare heart health problem induced by the Covid-19 vaccine is mild and resolves quickly, scientists say.

Myocarditis is a condition characterized by inflammation of the heart muscle and can reduce blood flow in the body. The most common cause is infection and in these cases it can be serious or even fatal.

Data shows that coronavirus vaccines increase a person’s risk of developing myocarditis, the risk being highest in young boys and after the second dose.

A group of experts from across the United States looked at 139 cases of vaccine-induced myocarditis in people between the ages of 12 and 20, with the average age being 16. Nine out of 10 cases were in boys and after a second dose.

Of the 139 people who went to hospital with the complaint, less than one in five were admitted to intensive care and none have died.

Chest pain was an almost ubiquitous symptom, and one in three people suffered from shortness of breath or fever.

“These data suggest that most cases of suspected myocarditis linked to the Covid-19 vaccine in people under the age of 21 are mild and resolve quickly,” said Dr. Dongngan Truong, study lead author and associate professor of Pediatrics at the University of Utah.

“This study confirms what we have seen – people identified and treated early and appropriately for Covid-19 vaccine-related myocarditis typically have mild cases and short recovery times,” added Dr Donald Lloyd-Jones , president of the American Heart Association.

“These results also support the American Heart Association’s position that Covid-19 vaccines are safe, highly effective, and fundamental to saving lives, protecting our families and communities from Covid-19, and ending the pandemic. Please get your child immunized as soon as possible.

According to data from the United Kingdom’s Joint Committee on Vaccination and Immunization (JCVI), for every million Covid vaccines given as a first dose to children aged 12 to 15, there are between 3 and 18 cases of myocarditis.

The level of risk increases for the second dose, however, between 21 and 42 cases per million second doses.

Concerns over this side effect led JCVI to be cautious and not initially recommend that those under 16 be given the jab, as the risk of Covid is so low.

Chief doctors in decentralized administrations, however, decided that the vaccine’s broader benefits meant that it should be rolled out, but only the first doses.

However, last week the JCVI announced it would start giving a second dose to 12-15 year olds, after more data was released.


Please enter your comment!
Please enter your name here